自1993年8月至1998年9月间,我们应用精制蝮蛇抗栓酶雾化吸入治疗喘憋型肺炎取得满意疗效,报告如下。1 临床资料 本组病例诊断均符合1987年成都会议制定的诊断标准。将200例患者随机分为两组,治疗组100例,男56例,女44冽。年龄1～6个月49例,7～12个月35例,13～36个月16例。普通型52例,重型48例。对照组 From August 1993 to September 1998, we applied refined viper antithrombin aerosol inhalation treatment of asthmatic pneumonia obtained satisfactory results, the report is as follows. 1 Clinical data The diagnosis of this group of patients are in line with the 1987 Chengdu meeting to develop diagnostic criteria. 200 patients were randomly divided into two groups, the treatment group of 100 patients, 56 males and 44 females. 49 cases were from 1 to 6 months, 35 cases were from 7 to 12 months and 16 cases were from 13 to 36 months. 52 cases of common type, 48 cases of heavy type. Control group